Long-term effects of adolescent exposure to olanzapine in C57BL/6 J mice and the impact of dietary fish oil supplementation

[1] Albracht-Schulte K(2018)Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update J Nutr Biochem 58 1-16

[2] Kalupahana NS(2019)The effects of amphetamine on working memory and locomotor activity in adult rats administered risperidone early in life Behav Brain Res 362 64-70

[3] Ramalingam L(2020)Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference Neuropharmacology 179 108276-267

[4] Wang S(2013)Adult rats treated with risperidone during development are hyperactive Exp Clin Psychopharmacol 21 259-1312

[5] Rahman SM(2018)Change in overweight from childhood to early adulthood and risk of type 2 diabetes N Engl J Med 378 1302-911

[6] Robert-McComb J(2008)Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyperphagia, and metabolic dysregulation in mice J Pharmacol Exp Ther 326 905-571

[7] Moustaid-Moussa N(2006)Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects Psychopharmacology 186 561-413

[8] Bardgett ME(2007)Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities J Psychopharmacol 21 405-614

[9] Crane C(2005)Antipsychotic drug-induced weight gain: development of an animal model Int J Obes (lond) 29 607-169

[10] Baltes Thompson EC(2012)Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters Psychopharmacology 221 155-214

[1] Albracht-Schulte K(2018)Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update J Nutr Biochem 58 1-16

[2] Kalupahana NS(2019)The effects of amphetamine on working memory and locomotor activity in adult rats administered risperidone early in life Behav Brain Res 362 64-70

[3] Ramalingam L(2020)Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference Neuropharmacology 179 108276-267

[4] Wang S(2013)Adult rats treated with risperidone during development are hyperactive Exp Clin Psychopharmacol 21 259-1312

[5] Rahman SM(2018)Change in overweight from childhood to early adulthood and risk of type 2 diabetes N Engl J Med 378 1302-911

[6] Robert-McComb J(2008)Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyperphagia, and metabolic dysregulation in mice J Pharmacol Exp Ther 326 905-571

[7] Moustaid-Moussa N(2006)Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects Psychopharmacology 186 561-413

[8] Bardgett ME(2007)Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities J Psychopharmacol 21 405-614

[9] Crane C(2005)Antipsychotic drug-induced weight gain: development of an animal model Int J Obes (lond) 29 607-169

[10] Baltes Thompson EC(2012)Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters Psychopharmacology 221 155-214